Who Supplies Ledipasvir? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Ledipasvir exports, with 60+ registered manufacturers shipping to buyers across 44+ countries — yet a handful of companies dominate the shipments. HETERO LABS LIMITED holds the largest share at 15.5% (export value: $175.7K). Close behind, SACRED LEAVES PRIVATE LIMITED (1.5%, $17.3K). ROYAL MEDICAL PRIVATE LIMITED (1.5%, $16.7K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Ledipasvir? Top Manufacturers & Their Buyers
Flow of Ledipasvir from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Ledipasvir Supplier Network — Key Market Intelligence
The Ledipasvir export market from India is led by HETERO LABS LIMITED, which alone commands a 15.5% share, shipping $175.7K worth of product across 15 shipments. The second-largest exporter, SACRED LEAVES PRIVATE LIMITED, contributes $17.3K (1.5%) to the overall market. Combined, the top two suppliers alone account for 17.0% of all Ledipasvir exports, indicating a relatively concentrated supply base.
Across all 60 tracked manufacturers, the total Ledipasvir export value stands at $1.1M from 228 shipments. The market average shipment value is $5.0K. The single largest buyer relationship in terms of trade value is IP LILI, receiving $6.2K worth of product.
The combined buyer network spans 9 named purchasing companies, including IP LILI, IP DIDI STREET MIKRORAION, IP DIDI, SAVCHUK LIUBOMYR, IP RIM and 4 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1HETERO LABS LIMITED
HETERO LABS LIMITED is the first-largest Ledipasvir exporter from India, with a market share of 15.5% and a total export value of $175.7K across 15 shipments. Their average shipment value of $11.7K is above the market average of $5.0K, suggesting premium or bulk contract pricing.
HETERO LABS LIMITED serves 3 named buyers in our database. MS is the dominant customer, accounting for 50.1% of this supplier's tracked business. Top customers include:
• MS — $88.1K across 8 shipments (50.1% of this supplier's total exports)
• MS — $87.6K across 7 shipments (49.9% of this supplier's total exports)
• TO THE ORDER — $36 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: HETERO LABS LIMITED's per-shipment value of $11.7K is 135% above the market average of $5.0K, consistent with large-order contracts or value-added formulations.
2SACRED LEAVES PRIVATE LIMITED
SACRED LEAVES PRIVATE LIMITED is the second-largest Ledipasvir exporter from India, with a market share of 1.5% and a total export value of $17.3K across 24 shipments. Their average shipment value of $719 is below the market average of $5.0K, reflecting a high-volume, competitive pricing strategy.
SACRED LEAVES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• IP LILI — $6.2K across 9 shipments (35.9% of this supplier's total exports)
• IP DIDI STREET MIKRORAION — $5.4K across 8 shipments (31.4% of this supplier's total exports)
• IP DIDI — $2.4K across 3 shipments (14.1% of this supplier's total exports)
• SAVCHUK LIUBOMYR — $2.0K across 3 shipments (11.3% of this supplier's total exports)
• IP RIM — $1.2K across 2 shipments (7.2% of this supplier's total exports)
Key Insight: SACRED LEAVES PRIVATE LIMITED operates with high shipment frequency (24 shipments) at a per-shipment value of $719, indicating a broad distribution network with many smaller, regular orders.
3ROYAL MEDICAL PRIVATE LIMITED
ROYAL MEDICAL PRIVATE LIMITED is the third-largest Ledipasvir exporter from India, with a market share of 1.5% and a total export value of $16.7K across 9 shipments. Their average shipment value of $1.9K is below the market average of $5.0K, reflecting a high-volume, competitive pricing strategy.
ROYAL MEDICAL PRIVATE LIMITED serves 3 named buyers in our database. TO THE ORDER OF INVO is the dominant customer, accounting for 67.2% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF INVO — $11.2K across 6 shipments (67.2% of this supplier's total exports)
• To The Order of — $3.5K across 2 shipments (20.9% of this supplier's total exports)
• TO THE ORDER OF — $2.0K across 1 shipments (11.9% of this supplier's total exports)
Key Insight: ROYAL MEDICAL PRIVATE LIMITED operates with high shipment frequency (9 shipments) at a per-shipment value of $1.9K, indicating a broad distribution network with many smaller, regular orders.
4MEHADIA TRADELINKS
MEHADIA TRADELINKS is the fourth-largest Ledipasvir exporter from India, with a market share of 1.4% and a total export value of $15.8K across 3 shipments. Their average shipment value of $5.3K is above the market average of $5.0K, suggesting premium or bulk contract pricing.
MEHADIA TRADELINKS serves 2 named buyers in our database. TO THE ORDER is the dominant customer, accounting for 96.8% of this supplier's tracked business. Top customers include:
• TO THE ORDER — $15.3K across 3 shipments (96.8% of this supplier's total exports)
• TO THE MANAGER — $499 across 0 shipments (3.2% of this supplier's total exports)
Key Insight: MEHADIA TRADELINKS's per-shipment value of $5.3K is 6% above the market average of $5.0K, consistent with large-order contracts or value-added formulations.
5OCEAN PHARMACEUTICAL
OCEAN PHARMACEUTICAL is the fifth-largest Ledipasvir exporter from India, with a market share of 0.2% and a total export value of $2.4K across 6 shipments. Their average shipment value of $395 is below the market average of $5.0K, reflecting a high-volume, competitive pricing strategy.
OCEAN PHARMACEUTICAL serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• LEXINGTON FREIGHT FO — $1.0K across 3 shipments (43.2% of this supplier's total exports)
• KEO AVIATION LTD — $990 across 3 shipments (41.8% of this supplier's total exports)
• FATIH PHARMA ILAC VE — $357 across 1 shipments (15.1% of this supplier's total exports)
Key Insight: OCEAN PHARMACEUTICAL operates with high shipment frequency (6 shipments) at a per-shipment value of $395, indicating a broad distribution network with many smaller, regular orders.
6MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the fifth-largest Ledipasvir exporter from India, with a market share of 0.0% and a total export value of $0 across 5 shipments. Their average shipment value of $0 is below the market average of $5.0K, reflecting a high-volume, competitive pricing strategy.
Key Insight: MYLAN LABORATORIES LIMITED operates with high shipment frequency (5 shipments) at a per-shipment value of $0, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Ledipasvir Flows
Once Ledipasvir leaves the manufacturing plants of companies like HETERO LABS LIMITED and SACRED LEAVES PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $1.1M. Kyrgyzstan absorbs the largest share at 20.1% ($228.2K), followed by Uzbekistan (18.7%) and Kenya (17.4%).
This geographic spread reflects Ledipasvir's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Ledipasvir Go? Top Importing Countries & Their Buyers
Trade flow of Ledipasvir exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Kyrgyzstan
Kyrgyzstan ranks as the first-largest destination for Ledipasvir imports from India, with a total trade value of $228.2K across 0 shipments — representing a 20.1% share of all Ledipasvir exports. The average shipment value of $228.2K is above the global average of $5.0K, indicating high-value procurement contracts or branded formulations.
Key Insight: Kyrgyzstan's per-shipment average of $228.2K (4484% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Kyrgyzstan is a key market for Ledipasvir imports from India.
2Uzbekistan
Uzbekistan ranks as the second-largest destination for Ledipasvir imports from India, with a total trade value of $211.7K across 0 shipments — representing a 18.7% share of all Ledipasvir exports. The average shipment value of $211.7K is above the global average of $5.0K, indicating high-value procurement contracts or branded formulations.
Key Insight: Uzbekistan's per-shipment average of $211.7K (4153% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Uzbekistan is a key market for Ledipasvir imports from India.
3Kenya
Kenya ranks as the third-largest destination for Ledipasvir imports from India, with a total trade value of $197.5K across 2 shipments — representing a 17.4% share of all Ledipasvir exports. The average shipment value of $98.7K is above the global average of $5.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Ledipasvir importers in Kenya: QUESTA CARE LIMITED is the largest buyer, accounting for 22.6% ($44.6K) of this market's total imports.
• QUESTA CARE LIMITED — $44.6K (22.6% of Kenya's total)
Key Insight: Kenya's per-shipment average of $98.7K (1883% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Kenya is a key market for Ledipasvir imports from India.
4Kazakhstan
Kazakhstan ranks as the fourth-largest destination for Ledipasvir imports from India, with a total trade value of $134.1K across 17 shipments — representing a 11.8% share of all Ledipasvir exports. The average shipment value of $7.9K is above the global average of $5.0K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Ledipasvir importers in Kazakhstan: IP DIDI is the largest buyer, accounting for 6.3% ($8.4K) of this market's total imports.
• IP DIDI — $8.4K (6.3% of Kazakhstan's total)
• IP LILI — $6.2K (4.6% of Kazakhstan's total)
• IP DIDI STREET MIKRORAION — $5.4K (4.0% of Kazakhstan's total)
Key Insight: Kazakhstan's per-shipment average of $7.9K (58% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Kazakhstan is a key market for Ledipasvir imports from India.
5Azerbaijan
Azerbaijan ranks as the fifth-largest destination for Ledipasvir imports from India, with a total trade value of $119.4K across 0 shipments — representing a 10.5% share of all Ledipasvir exports. The average shipment value of $119.4K is above the global average of $5.0K, indicating high-value procurement contracts or branded formulations.
Key Insight: Azerbaijan's per-shipment average of $119.4K (2298% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Azerbaijan is a key market for Ledipasvir imports from India.
People Also Ask — Ledipasvir Supplier & Trade Network
Who are the top suppliers of Ledipasvir from India?+
Which companies buy Ledipasvir from Indian manufacturers?+
Where does Ledipasvir exported from India go?+
What is the market share of the top Ledipasvir supplier from India?+
What is the average shipment value for Ledipasvir exports from India?+
Is Ledipasvir manufactured in India and exported globally?+
Which country imports the most Ledipasvir from India?+
Who are the buyers of Ledipasvir in Uzbekistan?+
How concentrated is the Ledipasvir supplier market in India?+
How do I find verified buyers for Ledipasvir in specific countries?+
Ledipasvir Trade Network — Key Takeaways
- 1HETERO LABS LIMITED is India's dominant Ledipasvir exporter with a 15.5% market share and $175.7K in total exports — making it the single most important sourcing entity in this market.
- 2The top 60 suppliers collectively account for 20.1% of all tracked Ledipasvir exports, with a combined trade value of $1.1M.
- 3Kyrgyzstan is the largest destination market, absorbing 20.1% of India's Ledipasvir exports ($228.2K). Uzbekistan (18.7%) and Kenya (17.4%) follow.
- 4With 228 total shipments averaging $5.0K each, the Ledipasvir export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include IP LILI, IP DIDI STREET MIKRORAION, TO THE MANAGER, LEXINGTON FREIGHT FO — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 3 customers
6 suppliers → 44 countries
Network value: $1.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ledipasvir — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Ledipasvir.
- 2.Flow Mapping: 60 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 228 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 44 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
228 Verified Shipments
60 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists